How 'people power' and business transformed medicine, but created a whole new set of risks

Дата публикации: 12-10-2026 15:20:02

There's been a shift in how some medicines and therapeutic products are accessed and used.

Основное содержимое страницы с новостью.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Eli Lilly is reinventing the pharma business	0	7.35	15-07-2026
2	Tariff-driven exim: Access does not guarantee success	0	11.77	15-02-2026
3	Telehealth companies keep exposing their customers' medical data. What should they do?	0	7.2	19-09-2026
4	The backlash against AI	0	8.62	28-05-2026
5	AI without the hype: What AML transformation means	0	9.07	06-10-2026
6	Rewiring early drug development with AI and digitalization	0	11.88	25-06-2026
7	Tariff-Proof But Not China-Proof: The Geopolitics of India’s Pharma Power	0	7	26-06-2026
8	From personalised workouts to instant feedback: Should you give AI fitness apps a chance?	0	5	02-07-2026
9	Wall Street’s insurance takeover presents circular risks and rewards	0	10	04-08-2026
10	The next ayahuasca? US drug companies are vying to get their hands on a mind-altering root bark used in Gabonese ritual traditions	0	12.11	20-10-2026

Классификация: . Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 7.51. Источник: medicalxpress.com.